[{"address1": "Dr. Neergaards Vej", "address2": "5th Floor", "city": "Horsholm", "zip": "2970", "country": "Denmark", "phone": "45 53 53 18 50", "website": "https://www.evaxion-biotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in H\u00f8rsholm, Denmark.", "fullTimeEmployees": 63, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christian  Kanstrup M.Sc.", "age": 51, "title": "Chief Executive Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 454000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andreas Holm Mattsson", "age": 47, "title": "Co-Founder and Chief AI & Culture Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 247000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Niels Iversen Moller M.D.", "age": 44, "title": "Co-Founder, VP of Business & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 120000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jesper Nyegaard Nissen M.Sc.", "age": 52, "title": "CFO & COO", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 346967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Birgitte  Rono Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 336000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. J\u00fcrgen  Langh\u00e4rig EMBA, Ph.D.", "title": "Head of Business Development & Member of Advisory Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 6.7, "open": 6.08, "dayLow": 3.36, "dayHigh": 6.1, "regularMarketPreviousClose": 6.7, "regularMarketOpen": 6.08, "regularMarketDayLow": 3.36, "regularMarketDayHigh": 6.1, "beta": 0.046, "forwardPE": -9.895135, "volume": 204214, "regularMarketVolume": 204214, "averageVolume": 13642, "averageVolume10days": 30034, "averageDailyVolume10Day": 30034, "bidSize": 900, "askSize": 800, "marketCap": 13878511, "fiftyTwoWeekLow": 3.36, "fiftyTwoWeekHigh": 21.1, "fiftyDayAverage": 7.254764, "twoHundredDayAverage": 10.30509, "currency": "USD", "enterpriseValue": 104642344, "floatShares": 19233296, "sharesOutstanding": 3790700, "sharesShort": 15575, "sharesShortPriorMonth": 23429, "sharesShortPreviousMonthDate": 1701302400, "dateShortInterest": 1703808000, "sharesPercentSharesOut": 0.0004, "shortRatio": 1.61, "shortPercentOfFloat": 0.0053, "impliedSharesOutstanding": 37907000, "bookValue": 0.092, "priceToBook": 39.795654, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -24474000, "trailingEps": -9.5, "forwardEps": -0.37, "lastSplitFactor": "1:10", "lastSplitDate": 1705881600, "enterpriseToEbitda": -4.386, "52WeekChange": -0.771175, "SandP52WeekChange": 0.20484698, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "EVAX", "underlyingSymbol": "EVAX", "shortName": "Evaxion Biotech A/S", "longName": "Evaxion Biotech A/S", "firstTradeDateEpochUtc": 1612535400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "10e58503-7bd5-32f9-974e-d651a4f9f505", "messageBoardId": "finmb_319014926", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.6612, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.5, "targetMedianPrice": 3.5, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 7118000, "totalCashPerShare": 0.257, "ebitda": -23857000, "totalDebt": 10492000, "debtToEquity": 413.886, "financialCurrency": "USD", "trailingPegRatio": null}]